Collaborative Wealth Managment Inc. Lowers Stock Holdings in Aflac Incorporated (NYSE:AFL)

Collaborative Wealth Managment Inc. reduced its stake in Aflac Incorporated (NYSE:AFL) by 5.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,634 shares of the financial services provider’s stock after selling 311 shares during the quarter. Collaborative Wealth Managment Inc.’s holdings in Aflac were worth $626,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. NorthRock Partners LLC lifted its holdings in shares of Aflac by 1.5% in the 1st quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock valued at $725,000 after buying an additional 95 shares during the period. Valued Wealth Advisors LLC lifted its holdings in shares of Aflac by 24.4% in the 1st quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider’s stock valued at $55,000 after buying an additional 97 shares during the period. Phillips Wealth Planners LLC lifted its holdings in shares of Aflac by 1.5% in the 1st quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider’s stock valued at $711,000 after buying an additional 100 shares during the period. Optas LLC lifted its holdings in shares of Aflac by 3.5% in the 1st quarter. Optas LLC now owns 2,949 shares of the financial services provider’s stock valued at $328,000 after buying an additional 101 shares during the period. Finally, Titleist Asset Management LLC lifted its holdings in shares of Aflac by 3.4% in the 4th quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider’s stock valued at $344,000 after buying an additional 110 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AFL has been the subject of several recent analyst reports. Morgan Stanley raised their price target on Aflac from $100.00 to $105.00 and gave the company an “equal weight” rating in a report on Monday, May 19th. Raymond James Financial reduced their price target on Aflac from $115.00 to $110.00 and set an “outperform” rating for the company in a report on Thursday, May 29th. Wells Fargo & Company lifted their price objective on Aflac from $103.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, July 10th. Barclays set a $98.00 price objective on Aflac and gave the stock an “underweight” rating in a report on Monday, July 7th. Finally, Piper Sandler lifted their price objective on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and an average target price of $108.15.

Insiders Place Their Bets

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director owned 26,096 shares of the company’s stock, valued at approximately $2,786,791.84. This trade represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Arthur Reginald Collins sold 2,750 shares of the company’s stock in a transaction on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the transaction, the director owned 6,728 shares of the company’s stock, valued at $711,149.60. The trade was a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 40,750 shares of company stock valued at $4,304,295. Corporate insiders own 0.90% of the company’s stock.

Aflac Stock Performance

Aflac stock opened at $98.57 on Thursday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.09 and a current ratio of 0.09. The stock has a fifty day moving average of $102.73 and a two-hundred day moving average of $105.11. The company has a market capitalization of $53.29 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 3.11 and a beta of 0.81. Aflac Incorporated has a fifty-two week low of $94.87 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last released its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to analysts’ expectations of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business’s quarterly revenue was down 37.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.66 EPS. On average, analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.